This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Hui Xiong: Innovator in Nicotinic Acetylcholine Receptor Ligands
Introduction
Hui Xiong is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmacology, particularly in the development of nicotinic acetylcholine receptor ligands. His work has implications for various therapeutic applications.
Latest Patents
Hui Xiong holds a patent for "Nicotinic acetylcholine receptor ligands 101." This patent describes nicotinic acetylcholine receptor ligands of Formula I, including diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing, and methods for using the same. He has 1 patent to his name.
Career Highlights
Hui Xiong is currently employed at AstraZeneca AB, where he continues to advance research in pharmacological innovations. His work at AstraZeneca has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Hui Xiong has collaborated with notable colleagues, including Hui-Fang Chang and Christopher Holmquist. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.
Conclusion
Hui Xiong's contributions to the field of pharmacology, particularly through his patent on nicotinic acetylcholine receptor ligands, highlight his innovative spirit and dedication to advancing medical science. His work at AstraZeneca and collaborations with esteemed colleagues further underscore his impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile